SLFN11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.200600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.106400E-02
Normal-vs-Stage2
2.830000E-01
Normal-vs-Stage3
1.702640E-01
Normal-vs-Stage4
5.566200E-01
Stage1-vs-Stage2
2.865000E-01
Stage1-vs-Stage3
6.481600E-01
Stage1-vs-Stage4
2.648000E-01
Stage2-vs-Stage3
6.205400E-01
Stage2-vs-Stage4
7.325600E-01
Stage3-vs-Stage4
4.601800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.705040E-01
Normal-vs-AfricanAmerican
5.851600E-01
Normal-vs-Asian
4.853200E-01
Caucasian-vs-AfricanAmerican
5.947000E-01
Caucasian-vs-Asian
8.766800E-01
AfricanAmerican-vs-Asian
8.584000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.596820E-01
Normal-vs-Female
3.273600E-01
Male-vs-Female
1.606440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.936190E-01
Normal-vs-Age(41-60Yrs)
3.239600E-01
Normal-vs-Age(61-80Yrs)
2.204200E-01
Normal-vs-Age(81-100Yrs)
1.213030E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.036200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.619400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.057600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.093200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.522840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.991600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.749500E-02
Normal-vs-Daily Drinker
2.169800E-02
Normal-vs-Weekly Drinker
9.949700E-02
Normal-vs-Occasional Drinker
1.771400E-01
Normal-vs-Social Drinker
5.478400E-01
Non Drinker-vs-Daily Drinker
2.716600E-01
Non Drinker-vs-Weekly Drinker
7.554400E-01
Non Drinker-vs-Occasional Drinker
7.737600E-01
Non Drinker-vs-Social Drinker
1.612200E-01
Daily Drinker-vs-Weekly Drinker
1.806230E-01
Daily Drinker-vs-Occasional Drinker
2.183800E-01
Daily Drinker-vs-Social Drinker
5.569600E-02
Weekly Drinker-vs-Occasional Drinker
9.856800E-01
Weekly Drinker-vs-Social Drinker
3.290600E-01
Occasional Drinker-vs-Social Drinker
3.277800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.585400E-01
Normal-vs-Grade 2
3.155000E-01
Normal-vs-Grade 3
2.895800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.744200E-02
Grade 1-vs-Grade 3
1.456620E-01
Grade 1-vs-Grade 4
6.585400E-01
Grade 2-vs-Grade 3
6.547000E-01
Grade 2-vs-Grade 4
3.155000E-01
Grade 3-vs-Grade 4
2.895800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.495600E-01
Normal-vs-NonDiabetic
1.267650E-01
Diabetic-vs-NonDiabetic
3.315400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.551500E-02
Normal-vs-NoPancreatitis
1.901420E-01
Pancreatitis-vs-NoPancreatitis
5.037200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.059000E-01
Normal-vs-N1
2.586600E-01
N0-vs-N1
3.112800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.803900E-02
Normal-vs-TP53-NonMutant
1.470810E-01
TP53-Mutant-vs-TP53-NonMutant
5.994400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
